The European Association of Nuclear Medicine (EANM) has responded to the European Thyroid Association's (ETA) clinical practice guidelines for thyroid nodule management. The EANM argues that the guidelines did not adequately address important aspects of nuclear medicine approaches and that nuclear medicine physicians were not included in the authors' panel. They believe there is a substantial gap in the guidelines, given that many European countries rely on nuclear medicine physicians for secondary care after nodule detection. The EANM also highlights concerns about the use of TIRADS systems, the lack of focus on nuclear medicine diagnostics, and the downgrading of radioiodine therapy. They suggest that the guidelines are unbalanced and biased, lacking adequate evidence in some sections. [Extracted from the article]